Ultrasound Gel Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Ultrasound Gel Market size was more than USD 108.87 million in 2026 and is set to grow at a 2.76% CAGR between 2027 and 2036, attaining USD 142.94 million by 2036. The industry revenue for 2027 is calculated at USD 111.4 million.
Get more details on this report
Request Free Sample ReportUltrasound Gel Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to diagnostic imaging volumes across hospitals, outpatient imaging centers, and physician offices, widespread ultrasound use in obstetric, abdominal, cardiovascular, and emergency care, and steady consumable demand.
- Europe is projected at 3.42% CAGR, driven by continued ultrasound utilization across public and private healthcare, maternal care, radiology, and point-of-care, with stable procedure demand supporting incremental growth.
Segment Momentum
- Non-sterile ultrasound gel held a 67.78% share in 2026 due to its widespread use in routine diagnostic imaging, cost-efficient procurement, and suitability for high-volume ultrasound procedures.
- Clinics are growing fastest as ultrasound services expand into outpatient settings, where increasing point-of-care imaging and higher patient throughput are driving greater gel consumption.
Market Expansion Drivers
- Increasing global ultrasound procedure volumes driving sustained demand for coupling and imaging enhancement gels.
- Rising adoption of point-of-care ultrasound systems increasing utilization of portable ultrasound consumables.
- Development of patient-friendly and contamination-resistant gel formulations improving healthcare provider adoption rates.
Leading Market Participants
- Prominent companies in the ultrasound gel market include Parker Laboratories, Inc. (United States), ECO-MED Pharmaceutical Inc. (Canada), Sonogel Vertriebs GmbH (Germany), HR Pharmaceuticals, Inc. (United States), Ultragel Kft. (Hungary), National Therapy Products Inc. (Canada), Tele-Paper Malaysia (Malaysia), Compass Health Brands Corp. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 108.87 million
- 2027 Estimated Market Size: USD 111.4 million.
- Projected Market Size: USD 142.94 million by 2036
- Growth Forecast: 2.76% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Europe
- Core Revenue Segment: Non-sterile (Type) | Hospitals (End-use)
- Emerging Opportunity Segment: Sterile (Type) | Clinics (End-use)
Market Growth Drivers and Industry Trends
Increasing global ultrasound procedure volumes driving sustained demand for coupling and imaging enhancement gels
The expanding use of ultrasound across diagnostic, monitoring, and procedural applications is increasing consumption of coupling media, making higher procedure volumes a direct contributor to the ultrasound gel market growth. Ultrasound gel facilitates effective transmission of acoustic energy between the transducer and the patient's skin by reducing air gaps that can interfere with image formation. Because gel is routinely applied during examinations and many procedural applications, greater utilization of ultrasound equipment across healthcare settings creates recurring demand for suitable coupling products.
Rising adoption of point-of-care ultrasound systems increasing utilization of portable ultrasound consumables
The growing deployment of point-of-care ultrasound is extending imaging capabilities beyond conventional radiology departments, strengthening the ultrasound gel market. Portable systems are increasingly used in emergency care, critical care, bedside assessment, and other clinical environments where rapid imaging can support immediate decision-making. The mobility and frequent deployment of these systems require convenient access to compatible consumables, including ultrasound gel, across multiple patient-care locations rather than limiting usage to dedicated imaging facilities.
Development of patient-friendly and contamination-resistant gel formulations improving healthcare provider adoption rates
Advances in gel formulations are addressing practical concerns related to patient comfort, hygiene, and clinical handling, supporting the ultrasound gel market growth. Products designed with improved skin compatibility can make repeated ultrasound examinations more comfortable, while contamination-resistant formulations and packaging can help healthcare providers maintain appropriate infection-control practices between procedures. These characteristics are particularly relevant in settings involving frequent examinations, sensitive patients, and procedures where maintaining clean equipment and consumables is essential.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing global ultrasound procedure volumes driving sustained demand for coupling and imaging enhancement gels | 1.70% | Low | North America, Asia Pacific | High | Near Term |
| Rising adoption of point-of-care ultrasound systems increasing utilization of portable ultrasound consumables | 1.40% | Moderate | North America, Europe | High | Mid Term |
| Development of patient-friendly and contamination-resistant gel formulations improving healthcare provider adoption rates | 1.10% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The ultrasound gel market was led by North America, which held the largest share in 2026, supported by extensive use of diagnostic and therapeutic ultrasound across hospitals, clinics, imaging centers, and outpatient facilities. High utilization of ultrasound procedures creates recurring demand for gels that facilitate acoustic transmission and maintain effective contact between transducers and the skin. Established healthcare infrastructure, strong diagnostic capabilities, and continued adoption of point-of-care imaging contribute to the region's sustained market position.
Europe (Fastest-Growing Region)
Europe is the fastest-growing regional market as healthcare systems continue to emphasize accessible diagnostic imaging, outpatient care, and efficient clinical workflows. Broader utilization of ultrasound across diagnostic, obstetric, cardiovascular, and musculoskeletal applications is supporting greater consumption of ultrasound gels. Attention to infection prevention and product quality is also encouraging healthcare providers to favor dependable formulations suited to diverse clinical environments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
High-Purity FormulationsGermany emphasizes ultrasound gel products that meet rigorous quality standards for diagnostic accuracy and patient safety. German healthcare facilities increasingly select formulations compatible with diverse imaging systems while supporting standardized clinical protocols.
France 🇫🇷
Patient-Centered ImagingFrance prioritizes ultrasound gel products that combine dependable imaging performance with enhanced patient experience. French healthcare providers increasingly prefer formulations designed for broad clinical compatibility, efficient use, and compliance with healthcare quality standards.
Italy 🇮🇹
Routine Diagnostic PerformanceItaly emphasizes reliable ultrasound gel supplies that support consistent imaging quality across hospitals and diagnostic centers. Italian healthcare providers focus on products that simplify daily clinical workflows while maintaining dependable performance for a wide range of ultrasound examinations.
Japan 🇯🇵
Precision Imaging SupportJapan focuses on ultrasound gels that ensure reliable acoustic transmission during routine and specialized imaging procedures. Japanese healthcare providers prioritize consistent product performance and ease of application across hospitals and outpatient diagnostic settings.
South Korea 🇰🇷
Versatile Clinical ApplicationsSouth Korea continues expanding the use of ultrasound gel across diagnostic imaging, emergency care, and point-of-care applications. South Korean healthcare facilities favor formulations that support efficient workflows while maintaining patient comfort and imaging consistency.
United States 🇺🇸
Clinical Imaging EfficiencyThe U.S. ultrasound gel market prioritizes high-quality formulations that support consistent image clarity across diagnostic and interventional procedures. Healthcare providers in the U.S. increasingly value products that improve workflow efficiency, patient comfort, and infection control practices.
Segment Leadership and Growth Trends
Ultrasound Gel Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Non-sterile (Largest Segment) vs Sterile (Fastest-Growing Segment)
The non-sterile segment led the ultrasound gel market with a 67.78% share in 2026, reflecting its widespread suitability for routine diagnostic ultrasound examinations where sterile conditions are not required. Its established use across general imaging applications supports recurring consumption and makes non-sterile formulations a practical choice for high-volume ultrasound procedures.
The sterile segment is expected to expand at the fastest pace, supported by growing requirements for ultrasound applications where infection-control considerations are particularly important. Its suitability for procedures involving greater sensitivity to contamination can encourage adoption as healthcare providers place increasing emphasis on maintaining controlled clinical environments and improving procedural safety.
End-use Segment Analysis: Hospitals (Largest Segment) vs Clinics (Fastest-Growing Segment)
In the ultrasound gel market, hospitals accounted for the largest share in 2026, reflecting their extensive diagnostic infrastructure and broad utilization of ultrasound across multiple medical departments. High procedure volumes and the integration of imaging into routine patient assessment sustain demand for ultrasound gel within hospital-based care.
Clinics are positioned as the fastest-growing end-use segment as diagnostic imaging becomes increasingly integrated into outpatient and specialized care settings. The expanding role of ultrasound in convenient clinical evaluation supports greater gel consumption, while the focus on accessible and efficient diagnosis can further strengthen adoption across clinic-based environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Sterile, Non-sterile | Non-sterile | Sterile |
| End-use | Hospitals, Diagnostic Centers, Clinics, Others | Hospitals | Clinics |
Competitive Landscape and Market Positioning
Prominent players in the ultrasound gel market:
1. Parker Laboratories Inc. (United States)
2. ECO-MED Pharmaceutical Inc. (Canada)
3. Sonogel Vertriebs GmbH (Germany)
4. HR Pharmaceuticals Inc. (United States)
5. Ultragel Kft. (Hungary)
6. National Therapy Products Inc. (Canada)
7. Tele-Paper Malaysia (Malaysia)
8. Compass Health Brands Corp. (United States)
The ultrasound gel market is evolving through the development of improved formulations that enhance imaging clarity, patient comfort, and compatibility with diagnostic equipment. Manufacturers are emphasizing sterile and hypoallergenic gel variants to address stricter healthcare safety standards. Ongoing investment in formulation stability and specialized application development is also supporting broader use across diagnostic and therapeutic procedures.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Parker Laboratories Inc. (United States) | |||||||
| ECO-MED Pharmaceutical Inc. (Canada) | |||||||
| Sonogel Vertriebs GmbH (Germany) | |||||||
| HR Pharmaceuticals Inc. (United States) | |||||||
| Ultragel Kft. (Hungary) | |||||||
| National Therapy Products Inc. (Canada) | |||||||
| Tele-Paper Malaysia (Malaysia) | |||||||
| Compass Health Brands Corp. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| TridentCare | Jul-25 | TridentCare partnered with Essence Healthcare to provide portable ultrasound diagnostic services directly to Medicare Advantage members in their homes and care facilities. This expanded mobile diagnostic model drives increased demand for single-use sterile ultrasound gel packettes, supporting the company's commitment to convenient, high-quality point-of-care imaging solutions for aging populations. |
| UPS | Jan-25 | UPS completed the acquisition of cold-chain logistics providers Frigo-Trans and BPL to strengthen its European healthcare distribution network. This expansion enhances the company's capability to manage temperature-sensitive medical supplies, including the secure, time-critical transportation and storage of ultrasound gels and other high-value diagnostic consumables across European markets. |
| EDM Medical Solutions | Jun-23 | EDM Medical Solutions entered a supplier partnership with CHAMPS Group Purchasing, gaining access to over 20,000 U.S. healthcare locations. This strategic agreement enables CHAMPS members to procure EDM’s medical imaging portfolio, including ultrasound gels and probe covers, at pre-negotiated pricing, significantly expanding the company’s distribution footprint in the U.S. clinical market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Ultrasound Gel Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Packaging Format | Bottles, Sachets & Pouches, Bulk Containers, Tubes & Other Formats |
| Distribution Channel | Direct Sales, Medical Distributors, Retail & Pharmacy Channels, Online Sales |
| Purchasing Model | Direct Institutional Procurement, Distributor-based Procurement, Group Purchasing Organization Procurement, Retail & Spot Purchasing |
Ultrasound Gel Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Imaging Procedure Demand Outlook |
|
| Infection Prevention and Single-Use Product Adoption |
|
| Private Label and Contract Manufacturing Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow large is the ultrasound gel market?
What is the anticipated CAGR of the ultrasound gel industry?
How is the expansion of point-of-care ultrasound influencing demand for ultrasound gel products?
Why are advanced ultrasound gel formulations becoming an important purchasing consideration?
Why does the Non-sterile segment hold the largest share of the ultrasound gel market?
Why are Clinics emerging as the fastest-growing end-use segment in the ultrasound gel market?
Why does North America lead ultrasound gel market?
How is Europe driving fastest growth in ultrasound gel market?
Who holds a significant market share in the ultrasound gel landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization